| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/08/2013 | CA2536471C Aav vectors for in vivo gene therapy of rheumatoid arthritis |
| 10/08/2013 | CA2453403C Methods of inhibiting amyloid toxicity |
| 10/08/2013 | CA2349839C Ucp5 |
| 10/08/2013 | CA2238893C Il-13 receptor polypeptide |
| 10/03/2013 | WO2013148987A1 Compositions and methods for treating intestinal bacterial infections |
| 10/03/2013 | WO2013148824A1 METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC-3 shRNA |
| 10/03/2013 | WO2013148305A1 Method for treating diabetic retinopathy |
| 10/03/2013 | WO2013147509A1 Epitopes of epidermal growth factor receptor surface antigen and use thereof |
| 10/03/2013 | WO2013147263A1 Novel use of acetyltransferase competitive inhibitory factor gm16515 |
| 10/03/2013 | WO2013147232A1 Bionanocapsule having antibody against surface protein of dendritic cell |
| 10/03/2013 | WO2013147140A1 Nucleic acid molecule capable of inhibiting expression of periostin gene, method for inhibiting expression of periostin gene, and use of said nucleic acid molecule |
| 10/03/2013 | WO2013143683A1 Rna formulation for immunotherapy |
| 10/03/2013 | WO2013143555A1 Rna formulation for immunotherapy |
| 10/03/2013 | WO2013119880A9 Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
| 10/03/2013 | US20130260453 Method for expression of small rna molecules within a cell |
| 10/02/2013 | EP2644697A1 Neuron-specific retrograde transport vector |
| 10/02/2013 | EP2644594A1 Cancer Cell Targeting Using Nanoparticles |
| 10/02/2013 | EP2644199A1 Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents |
| 10/02/2013 | EP2643018A2 Anti-il-6 antibodies for the treatment of oral mucositis |
| 10/02/2013 | EP2643016A2 Anti-il-6 antibodies for the treatment of anemia |
| 10/02/2013 | EP2642937A2 Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
| 10/02/2013 | DE102004037611B4 Induzierbare Genexpression Inducible gene expression |
| 10/02/2013 | CN103333919A Viruses AAVSTF for expressing iron nano particles and temperature-sensitive channel and application thereof |
| 10/02/2013 | CN103333906A CaMEK gene and recombinant virus vector as well as applications thereof |
| 10/02/2013 | CN103333900A Gene for preventing toxoplasma infection and application of gene |
| 10/02/2013 | CN103333895A Nucleic acid aptamer specifically binding to human epidermal growth factor acceptor III type mutant and applications thereof |
| 10/02/2013 | CN103333893A sHRNA (short hairpin ribonucleic acid) for inhibiting expression of human oral cancer cell PRPS2 (phosphoribosyl pyrophosphate synthetase subunit II) as well as construction and application of carrier of sHRNA |
| 10/02/2013 | CN103333892A Small interference RNA aiming at HPV16E7 gene, and application thereof |
| 10/02/2013 | CN103333891A Small interference RNA aiming at HPV16E7 gene, and application thereof |
| 10/02/2013 | CN103333890A RNA interference preparation used for treating viral hepatitis B |
| 10/02/2013 | CN103333255A Long-acting HIV-1 (Human Immunodeficiency Virus-1) membrane fusion inhibitor |
| 10/02/2013 | CN103333249A PSMA (Prostate Specific Membrane Antigen) monoclonal antibody and applications thereof |
| 10/02/2013 | CN103330947A Vaccine for preventing toxoplasma infection and application thereof |
| 10/02/2013 | CN102603898B Fowl adenovirus group I immunity related fusion protein as well as encoding gene and application thereof |
| 10/02/2013 | CN102552947B Cation microvesicle and preparation method thereof |
| 10/02/2013 | CN102260712B Construction and application of type B adenovirus hominis Ad11 mutant with enhanced tumor dissolving ability |
| 10/02/2013 | CN102178690B Preparation method of EGS nucleic acid drug for resisting influenza virus |
| 10/01/2013 | US8546554 Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene |
| 10/01/2013 | US8546538 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis |
| 10/01/2013 | US8546350 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs |
| 10/01/2013 | US8546346 Methods to reprogram splice site selection in pre-messenger RNAs |
| 10/01/2013 | US8546345 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer |
| 10/01/2013 | US8546143 Compositions and methods for inhibiting expression of a target gene |
| 10/01/2013 | US8545858 Porous calcium phosphate bone material |
| 10/01/2013 | US8545834 G-substrate for the treatment and prevention of parkinson's disease |
| 10/01/2013 | US8545833 Treatment of radiation injury using placental stem cells |
| 10/01/2013 | CA2689741C Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 10/01/2013 | CA2535770C Method for detecting cancer cells and monitoring cancer therapy |
| 10/01/2013 | CA2522625C Magnetically controllable drug and gene delivery stents |
| 10/01/2013 | CA2504694C Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 10/01/2013 | CA2495456C Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 10/01/2013 | CA2479835C An ephrin-b receptor protein involved in carcinoma |
| 10/01/2013 | CA2436530C Environmentally regulated genes of streptococcus suis |
| 09/26/2013 | WO2013142809A1 Baculovirus-based enterovirus 71 vlp as a vaccine |
| 09/26/2013 | WO2013142153A2 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
| 09/26/2013 | WO2013141133A1 Method for producing viral vector |
| 09/26/2013 | WO2013139300A1 Recombinant lentiviral vector formulation |
| 09/26/2013 | WO2013090732A3 Collateral gene inactivation biomarkers and targets for cancer therapy |
| 09/26/2013 | US20130252325 Duplexed Parvovirus Vectors |
| 09/26/2013 | US20130251746 Methods and Compositions for Poxvirus A35R Protein |
| 09/26/2013 | US20130251739 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/26/2013 | US20130251693 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
| 09/26/2013 | US20130251679 Long lasting drug formulations |
| 09/26/2013 | US20130251674 Non-Aqueous Single Phase Vehicles and Formulations Utilizing Such Vehicles |
| 09/25/2013 | EP2641970A1 Modulation of gene expression by oligomers targeted to chromosomal DNA |
| 09/25/2013 | EP2641617A1 Methods and compositions for mitochondrial replacement therapy |
| 09/25/2013 | EP2640853A2 Modulation of alpha synuclein expression |
| 09/25/2013 | EP2640700A1 Amine-containing transfection reagents and methods for making and using same |
| 09/25/2013 | EP2640426A1 Immunostimulatory oligonucleotides |
| 09/25/2013 | EP2640425A2 Methods of treating obesity by inhibiting nicotinamide n-methyl transferase (nnmt) |
| 09/25/2013 | EP2640420A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 09/25/2013 | EP2640417A2 Multivalent vaccine for filariasis |
| 09/25/2013 | CN103328633A Nucleic acid molecules inducing RNA interference, and uses thereof |
| 09/25/2013 | CN103328542A Cationic polymers formed from amino group-bearing monomers and heterocyclic linkers |
| 09/25/2013 | CN103328504A Delivery of a selectively replicating herpes simplex viral vector to the brain by convection- enhanced delivery (CED) |
| 09/25/2013 | CN103328009A Use of a DNA expression construct |
| 09/25/2013 | CN103320444A Antisense oligonucleotide for tiny RNA-21 seed sequence and application thereof |
| 09/25/2013 | CN103320440A SiRNA specifically inhibiting breast cancer MDA-MB-468 cell proliferation, and application thereof |
| 09/25/2013 | CN103320439A Small nucleic acid activator specifically enhancing miR-34a promoter transcriptional activity |
| 09/25/2013 | CN103319733A Method for preparing glycan-negative ion polysaccharide compound nanoparticles from micro-emulsions |
| 09/25/2013 | CN103319604A Human rotavirus Delta VP8* subunit recombinant protein and application thereof |
| 09/25/2013 | CN103319596A Compositions and methods for increasing bone mineralization |
| 09/25/2013 | CN103319579A Protein AFLA-216 associated with azole drug sensitivity in aspergillus flavus as well as encoding gene and application thereof |
| 09/25/2013 | CN103319577A Haemophilus parasuis (Hps) immunoprotecive antigen OppA |
| 09/25/2013 | CN103319576A Haemophilus parasuis (Hps) immunoprotecive antigen AfuA |
| 09/25/2013 | CN103319575A Haemophilus parasuis (Hps) immunoprotecive antigen CdtB |
| 09/25/2013 | CN103316359A Application of long-chain non-coding RNA in preparation of non-small cell lung cancer treatment drugs |
| 09/25/2013 | CN103316358A Bivalent DNA (Deoxyribonucleic Acid) vaccine and preparation method thereof |
| 09/25/2013 | CN103316357A Recombinant influenza virus chimeric vaccine carrying RSV gene, and preparation method thereof |
| 09/25/2013 | CN103316356A Recombinant lentivirus vector preparation |
| 09/25/2013 | CN102935239B Preparation for preventing or treating lung cancers and preparation method and application thereof |
| 09/25/2013 | CN102558158B Hairpin polyamide modified by or free of beta-hydroxyl-gamma-amino acid and preparation method and application |
| 09/25/2013 | CN101421293B Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/24/2013 | US8541628 cytofectins; delivering an anionic molecule into a cell by complexing with cationic lipids of invention |
| 09/24/2013 | US8541568 Compositions and methods using siRNA molecules for treatment of gliomas |
| 09/24/2013 | US8541565 Polynucleotide encoding anti-CD14 antibody fusion protein |
| 09/24/2013 | US8541550 Methods and compositions for delivering polynucleotides |
| 09/24/2013 | US8541390 Treatment of cancer by inhibition of IGFBPs and clusterin |
| 09/24/2013 | US8541388 Methods for modulating expression of RBP4 |
| 09/24/2013 | US8541387 Modulation of SMRT expression |